Kinaxis Inc. (TSE:KXS - Get Free Report) Senior Officer Christopher John Blaine Fitzgerald sold 2,177 shares of the business's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of C$156.26, for a total transaction of C$340,172.58.
Kinaxis Price Performance
Shares of Kinaxis stock traded down C$2.81 during trading hours on Tuesday, reaching C$156.78. The stock had a trading volume of 51,019 shares, compared to its average volume of 90,792. The stock's 50 day moving average is C$165.82 and its 200 day moving average is C$165.33. The firm has a market capitalization of C$3.15 billion, a PE ratio of 155.60, a PEG ratio of 3.60 and a beta of 0.78. Kinaxis Inc. has a twelve month low of C$132.93 and a twelve month high of C$190.17. The company has a current ratio of 1.89, a quick ratio of 2.29 and a debt-to-equity ratio of 12.12.
Wall Street Analysts Forecast Growth
Separately, CIBC decreased their target price on shares of Kinaxis from C$175.00 to C$170.00 in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of C$192.00.
Get Our Latest Analysis on KXS
Kinaxis Company Profile
(
Get Free Report)
Kinaxis Inc provides cloud-based subscription software for supply chain operations in the United States, Europe, Asia, and Canada. It offers RapidResponse, a cloud-based platform, which provides advanced planning, sales and operation planning, supply and demand planning, inventory management, and command and control center services.
Read More

Before you consider Kinaxis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.
While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.